Ferda retweeted
🧬 Great to see Dr @AntigoniGogolou presenting FGSL's arrayed CRISPR screening work in patient-derived intestinal organoids at @ELRIG_SCIENCE Drug Discovery 2026! #ELRIGDD26!
A fantastic collaboration between @TheMilnerInst, @AstraZeneca and @SCICambridge.
#ELRIG #ELRIGDD26
Ferda retweeted
More about the heart's hidden shield against cancer nature.com/articles/s41467-0… @AmidShakeri @NatureComms @FishLab_UHN @UHN_Research
Ferda retweeted
This is the final piece in the "thinking like a scientist" series, which will hopefully bring together all the previous concepts. As always, I would love to hear your thoughts.
Thinking like a Scientist: the flatlander’s problem network.febs.org/posts/think… #FEBSnet
📣 The Munich Center for Quantum Science and Technology (MCQST) offers two MCQST Postdoc Fellowships: fully funded, two-year postdoctoral positions for early-career researchers in quantum science and technology. 🗓️ Apply by 24 October here 👉 sohub.io/ensk
Animal-free FBS replacement now available from Qkine
Media City Scientific products now available -
🧪 FRS™ Pioneer – Fetal bovine serum replacement > zurl.co/hpfi9
🧪 GECKO™ – adherence solution > zurl.co/viJeZ
#humanspecific #animalfree #3rs
Ferda retweeted
Manipulation of protein translation and stem cell self-renewal by CRISPR activation of rRNA transcription
science.org/doi/10.1126/scie…
Ferda retweeted
Another glimmer of hope for our COPD patients!
Tozorakimab to Prevent COPD Exacerbations | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
@CHESTAirways @BCMLungInst @BCM_Lung
Ferda retweeted
Ready to kick off #ERSCongress 2026?
Join us on 5 September at 18:00 CEST as we officially begin this year's Congress.
Find out more: ersnet.org/congress-and-even…
Ferda retweeted
Join us on Monday for a Respiratory News Live special edition!
📅 24 August, 18:30 CEST
📍 Online
This broadcast will preview the ERS Congress 2026 in Barcelona (5–9 September), including late-breaking trials, key sessions, new ERS guidelines & more: channel.ersnet.org/media-122…
Ferda retweeted
Replying to @biorxivpreprint
@biorxivpreprint In vivo cellular localisation and nanoscale organisation of NLRP3 inflammasomes
biorxiv.org/content/10.64898…
Ferda retweeted
Join my new group at the University of Oxford! We are looking for a data analyst to examine our world leading EMBARC database. Work with experts to find new insights in lung disease with big data!
Join us!
my.corehr.com/pls/uoxrecruit…
@MereteLong @beccahull_
Ferda retweeted
🫁 💊 Are you interested in mechanisms of inflammation #asthma?
🧬 Keen to be involved in a human challenge study + molecular bio tools?
🏢 Want to work @HLRI_Cambridge?
🤓Then apply for @The_MRC funded Research Assistant post!
🗓️ Apply by 28th June
cam.ac.uk/jobs/research-assi…
Ferda retweeted
We're hiring multiple positions! 🧬🤖
Postdoctoral Fellows / Senior Postdocs (🌍 Visa sponsorship available | 3-year positions) — Machine Learning for Single Cell and Tissue Genomics — joining our group @sangerinstitute and @Cambridge_Uni
Work at the intersection of single-cell genomics, spatial transcriptomics & generative AI to build next-gen models of tissue biology.
Research directions include:
• Spatial/multi-omics atlases of diseased tissues
• Generative and agentic AI for cell fate engineering & perturbation responses
• Foundation models for genomics
• Multimodal learning (imaging + genomics + clinical data)
• Patient stratification for equitable women's health
We welcome biology-driven scientists and ML/AI methods developers. Strong computational background + PhD required.
Apply here : sanger.wd103.myworkdayjobs.c…
Learn more about our lab: lotfollahi.com/research/
#Postdoc #SingleCell #GenAI #SpatialTranscriptomics #TissueGenomics #MachineLearning #Hiring
Ferda retweeted
Excited to share some good news - I am starting my own lab at the Gurdon Institute, University of Cambridge, supported by an MRC Career Development Award. Exciting times ahead! 🥳🎉
Recruiting soon - stay tuned!
gurdon.cam.ac.uk/people/mari…
@The_MRC @GurdonInstitute @Cambridge_Uni
Ferda retweeted
Huge news for COPD as Tozorakimab hits primary endpoints in both phase 3 trials (Titania and Oberon)
A new anti-inflammatory Tx for COPD regardless of eosinophils could be a game changer. No effect size in the press release so need to see the full data
astrazeneca.com/media-centre…
Nature research paper: Precancerous niche remodelling dictates nascent tumour persistence
go.nature.com/4u8XPMQ
Ferda retweeted
Today in Istanbul, the trial of 402 defendants begins, including the city’s mayor Ekrem İmamoğlu, one of the leading figures of the Turkish opposition.
With a 3,900-page indictment, severe restrictions on lawyers and journalists, and a ban on demonstrations, İmamoğlu’s real “crime” appears to be leading in the polls and representing a democratic alternative to President Erdoğan.
When justice becomes a political weapon, democracy itself is being dismantled.
Ferda retweeted
Thanks for featuring our work on how emerging tumour remodel their nascent niche 🌱promoting their survival @Cambridge_Uni, @SCICambridge, @CRUKCamCentre, @PDN_Cambridge
stemcells.cam.ac.uk/news/alc…
✨@GSkrupskelyte, Eduardo Rojo, Harikrishnan Ajith
nature.com/articles/s41586-0…
Ferda retweeted
🚨 New paper from our lab just published in Nature🚨bit.ly/46G8ggV
Discover how 🌱 tumour formation is shaped by tissue context from the very beginning.
Fantastic team led by @GSkrupskelyte, Eduardo Rojo, Harikrishnan Ajith



























